An Asthma Mobile Intervention to Promote Patient-Reported Outcomes in Primary Care

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

110 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-03-01

Study Completion Date

2023-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Through this study, the investigators will adapt the ASTHMAXcel mobile app and evaluate the adapted intervention through a randomized controlled trial.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Adapting and Expanding the Asthma-Educator App

NCT03930381

Asthma

COMPLETED NA

ASTHMA-Educator Mobile Application Manage Asthma

NCT03518879

Asthma

COMPLETED NA

ASTHMAXcel Emergency Department Study

NCT05013073

Asthma Asthma Attack

TERMINATED NA

ASTHMAXcel Voice Study

NCT06935084

Asthma

RECRUITING NA

Promoting Asthma Management Guidelines With Technology-Based Intervention and Care Coordination in Clinics and Schools

NCT07224061

Asthma in Children

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Through this study, the investigators will use patient and provider feedback to adapt the ASTHMAXcel mobile intervention, and will conduct a randomized controlled trial to test the intervention's impact on clinical and process outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Through the randomized controlled trial component, there will be 2 arms, which include the ASTHMAXcel intervention and usual care delivered through the outpatient primary care setting.

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ASTHMAXcel arm

The ASTHMAXcel arm represents the study intervention, which is a patient-facing mobile application for adult patients with asthma.

Group Type EXPERIMENTAL

ASTHMAXcel mobile application

Intervention Type OTHER

ASTHMAXcel is a mobile application (patient-facing) that delivers guideline-based asthma education.

Usual care arm

This arm represents usual care delivered in the outpatient primary care setting at the study sites.

Group Type ACTIVE_COMPARATOR

Outpatient primary care

Intervention Type OTHER

Usual care delivered through the outpatient primary care setting

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ASTHMAXcel mobile application

ASTHMAXcel is a mobile application (patient-facing) that delivers guideline-based asthma education.

Intervention Type OTHER

Outpatient primary care

Usual care delivered through the outpatient primary care setting

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

English-speaking individuals \>18 years with:

1. persistent asthma(diagnosis made by a healthcare provider) on a daily controller medication
2. able to give informed consent
3. Smartphone (iOS or Android) access

Exclusion Criteria

1. use of oral corticosteroids in the 2 weeks prior to the baseline visit
2. pregnancy
3. severe psychiatric or cognitive problems that would prohibit an individual from completing the protocol
4. patients that previously received ASTHMAXcel

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No